Skip to Content
Cytokeratin 6a Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : KRT6A
GeneID : 3853
Uniprot : P02538
Specificity : Cytokeratin 6a Antibody detects endogenous levels of total Cytokeratin 6a.
Immunogen : A syntheVolumed peptide derived from human Cytokeratin 6a, corresponding to a region within N-terminal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat
Prediction : Bovine,Dog
Application : WB,IHC,ELISA(peptide)
Dilution : WB 1 : 1000-3000, IHC 1 : 200, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2841246
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF7789-BP
Des# Blocking Peptide : Cytokeratin 6a Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytokeratin 6 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : KRT6A,KRT6B,KRT6C
GeneID : 3853,3854,286887
Uniprot : P02538/P04259/P48668
Specificity : Cytokeratin 6 Antibody detects endogenous levels of total Cytokeratin 6.
Immunogen : A syntheVolumed peptide derived from human Cytokeratin 6, corresponding to a region within C-terminal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human
Prediction :
Application : WB,ELISA(peptide)
Dilution : WB 1 : 1000-3000, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2842207
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF9011-BP
Des# Blocking Peptide : Cytokeratin 6 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytokeratin 5 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : KRT5
GeneID : 3852
Uniprot : P13647
Specificity : Cytokeratin 5 Antibody detects endogenous levels of total Cytokeratin 5.
Immunogen : A syntheVolumed peptide derived from human Cytokeratin 5, corresponding to a region within C-terminal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat
Prediction : Bovine,Horse,Rabbit
Application : WB,IHC,IF/ICC,ELISA(peptide)
Dilution : WB : 1 : 500-1 : 3000, IHC : 1 : 50-1 : 200, IF/ICC 1 : 100-1 : 500, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2833387
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : AF0194-BP
Des# Blocking Peptide : Cytokeratin 5 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytokeratin 4 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName :
GeneID :
Uniprot : P19013
Specificity : Cytokeratin 4 Antibody detects endogenous levels of total Cytokeratin 4.
Immunogen : A syntheVolumed peptide derived from human Cytokeratin 4, corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat
Prediction : Pig,Horse,Sheep,Rabbit
Application : WB,IHC,ELISA(peptide)
Dilution : WB 1 : 500-1 : 2000, IHC 1 : 50-1 : 200, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2839006
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF7050-BP
Des# Blocking Peptide : Cytokeratin 4 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytokeratin 2e Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : KRT2
GeneID : 3849
Uniprot : P35908
Specificity : Cytokeratin 2e Antibody detects endogenous levels of total Cytokeratin 2e.
Immunogen : A syntheVolumed peptide derived from human Cytokeratin 2e, corresponding to a region within N-terminal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human
Prediction : Pig,Rabbit,Dog
Application : WB,ELISA(peptide)
Dilution : WB 1 : 1000-3000, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2842204
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF9008-BP
Des# Blocking Peptide : Cytokeratin 2e Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytokeratin 20 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : KRT20
GeneID : 54474
Uniprot : P35900
Specificity : Cytokeratin 20 Antibody detects endogenous levels of total Cytokeratin 20.
Immunogen : A syntheVolumed peptide derived from human Cytokeratin 20, corresponding to a region within C-terminal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat
Prediction : Bovine,Horse,Sheep,Chicken
Application : WB,IHC,IF/ICC,ELISA(peptide)
Dilution : WB : 1 : 500-1 : 3000, IHC : 1 : 50-1 : 200, IF/ICC 1 : 100-1 : 500, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2833386
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : AF0193-BP
Des# Blocking Peptide : Cytokeratin 20 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytokeratin 19 specific antibody
Volume : 100 µg
Purification : Immunogen affinity purified
Form : liquid
Purity : 95% as determined by SDS-PAGE
Host : Rabbit
Clonality : polyclonal Ab
Clone ID :
Isotype : IgG
Storage : PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20? for 12 months(Avoid repeated freeze / thaw cycles.)
Background :
Immunogen : keratin 19
Aliases :
Observed MW : 40 kDa
Uniprot ID : P08727
Reactivity : Human
Application : ELISA, WB, IHC
Recommended dilution : WB : 1 : 500-1 : 1000; IHC : 1 : 20-1 : 200
Gene ID :
Research Area : Stem Cells, Immunology, Cancer
0.01 0.01 USD
Cytokeratin 19 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : KRT19
GeneID : 3880
Uniprot : P08727
Specificity : Cytokeratin 19 Antibody detects endogenous levels of total Cytokeratin 19.
Immunogen : A syntheVolumed peptide derived from human Cytokeratin 19, corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat
Prediction : Bovine,Rabbit,Chicken
Application : WB,IHC,IF/ICC,IHC-F,ELISA(peptide)
Dilution : WB : 1 : 500-1 : 3000, IHC : 1 : 50-1 : 200, IF/ICC 1 : 200, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2833385
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : AF0192-BP
Des# Blocking Peptide : Cytokeratin 19 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytokeratin 18 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : KRT18
GeneID : 3875
Uniprot : P05783
Specificity : Cytokeratin 18 Antibody detects endogenous levels of total Cytokeratin 18.
Immunogen : A syntheVolumed peptide derived from human Cytokeratin 18, corresponding to a region within C-terminal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat
Prediction : Pig,Sheep,Rabbit
Application : WB,IHC,IF/ICC,ELISA(peptide)
Dilution : WB : 1 : 500-1 : 3000, IHC : 1 : 50-1 : 200, IF/ICC : 1 : 100-1 : 500, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2833384
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : AF0191-BP
Des# Blocking Peptide : Cytokeratin 18 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytokeratin 17 Specific antibody
Volume : 100 µg
Purification : Immunogen affinity purified
Form : liquid
Purity : 95% as determined by SDS-PAGE
Host : Rabbit
Clonality : polyclonal Ab
Clone ID :
Isotype : IgG
Storage : PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20? for 12 months(Avoid repeated freeze / thaw cycles.)
Background :
Immunogen : keratin 17
Aliases :
Observed MW : 48 kDa
Uniprot ID : Q04695
Reactivity : Human, Mouse, Rat
Application : ELISA, WB, IHC, IF, IP
Recommended dilution : WB : 1 : 500-1 : 2000; IP : 1 : 500-1 : 2000; IHC : 1 : 50-1 : 500; IF : 1 : 50-1 : 500
Gene ID :
Research Area : Cancer, Immunology
0.01 0.01 USD
Cytokeratin 17 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : KRT17
GeneID : 3872
Uniprot : Q04695
Specificity : Cytokeratin 17 Antibody detects endogenous levels of total Cytokeratin 17.
Immunogen : A syntheVolumed peptide derived from human Cytokeratin 17, corresponding to a region within C-terminal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat
Prediction : Zebrafish,Bovine,Horse,Sheep,Rabbit,Dog
Application : WB,IHC,IF/ICC,ELISA(peptide)
Dilution : WB : 1 : 500-1 : 3000, IHC : 1 : 50-1 : 200, IF/ICC : 1 : 100-1 : 500, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2833383
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : AF0190-BP
Des# Blocking Peptide : Cytokeratin 17 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytokeratin 16 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : KRT16
GeneID : 3868
Uniprot : P08779
Specificity : Cytokeratin 16 Antibody detects endogenous levels of total Cytokeratin 16.
Immunogen : A syntheVolumed peptide derived from human Cytokeratin 16, corresponding to a region within C-terminal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat
Prediction : Rabbit
Application : WB,IHC,IF/ICC,ELISA(peptide)
Dilution : WB : 1 : 500-1 : 3000, IHC : 1 : 50-1 : 200, IF/ICC 1 : 100-1 : 500, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2833382
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : AF0189-BP
Des# Blocking Peptide : Cytokeratin 16 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytokeratin 15 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : KRT15
GeneID : 3866
Uniprot : P19012
Specificity : Cytokeratin 15 Antibody detects endogenous levels of total Cytokeratin 15.
Immunogen : A syntheVolumed peptide derived from human Cytokeratin 15, corresponding to a region within N-terminal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat,Monkey
Prediction : Pig,Bovine,Sheep
Application : WB,IHC,IF/ICC,ELISA(peptide)
Dilution : WB 1 : 500-1 : 2000, IHC 1 : 50-1 : 200, IF/ICC 1 : 100-1 : 500, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2834151
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : AF0790-BP
Des# Blocking Peptide : Cytokeratin 15 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytokeratin 14/16 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : KRT14,KRT16
GeneID : 38613868
Uniprot : P02533/P08779
Specificity : Cytokeratin 14/16 Antibody detects endogenous levels of total Cytokeratin 14/16.
Immunogen : A syntheVolumed peptide derived from human Cytokeratin 14/16, corresponding to a region within N-terminal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat
Prediction : Pig,Rabbit,Dog
Application : WB,IHC,IF/ICC,ELISA(peptide)
Dilution : WB 1 : 500-1 : 2000, IHC 1 : 50-1 : 200, IF/ICC 1 : 100-1 : 500, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2834150
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : AF0736-BP
Des# Blocking Peptide : Cytokeratin 14/16 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytokeratin 14 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : KRT14
GeneID : 3861
Uniprot : P02533
Specificity : Cytokeratin 14 Antibody detects endogenous levels of total Cytokeratin 14.
Immunogen : A syntheVolumed peptide derived from human Cytokeratin 14, corresponding to a region within N-terminal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat
Prediction : Pig,Rabbit,Dog
Application : WB,IHC,IF/ICC,ELISA(peptide)
Dilution : WB 1 : 500-1 : 2000, IHC 1 : 50-1 : 200, IF/ICC 1 : 100-1 : 500, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2837711
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : AF5225-BP
Des# Blocking Peptide : Cytokeratin 14 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytokeratin 13 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : KRT13
GeneID : 3860
Uniprot : P13646
Specificity : Cytokeratin 13 Antibody detects endogenous levels of total Cytokeratin 13.
Immunogen : A syntheVolumed peptide derived from human Cytokeratin 13, corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat
Prediction : Horse,Dog
Application : WB,IHC,IF/ICC,ELISA(peptide)
Dilution : WB 1 : 500-1 : 2000, IHC 1 : 50-1 : 200, IF/ICC 1 : 100-1 : 500, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2837588
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : AF5102-BP
Des# Blocking Peptide : Cytokeratin 13 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytokeratin 10 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : KRT10
GeneID : 3858
Uniprot : P13645
Specificity : Cytokeratin 10 Antibody detects endogenous levels of total Cytokeratin 10.
Immunogen : A syntheVolumed peptide derived from human Cytokeratin 10, corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat
Prediction : Pig,Bovine,Sheep,Rabbit,Dog
Application : WB,IHC,IF/ICC,ELISA(peptide)
Dilution : WB : 1 : 500-1 : 3000, IF/ICC : 1 : 100-1 : 500, IHC 1 : 50-1 : 200, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2833390
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : AF0197-BP
Des# Blocking Peptide : Cytokeratin 10 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytokeratin 1 specific antibody
Volume : 100 µg
Purification : Immunogen affinity purified
Form : liquid
Purity : 95% as determined by SDS-PAGE
Host : Rabbit
Clonality : polyclonal Ab
Clone ID :
Isotype : IgG
Storage : PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20? for 12 months(Avoid repeated freeze / thaw cycles.)
Background : Keratins are a large family of proteins that form the intermediate filament cytoskeleton of epithelial cells, which are classified into two major sequence types. Type I keratins are a group of acidic intermediate filament proteins, including K9–K23, and the hair keratins Ha1–Ha8. Type II keratins are the basic or neutral courterparts to the acidic type I keratins, including K1–K8, and the hair keratins Ha1–Ha8. Type II keratins are the basic or neutral courterparts to the acidic type I keratins, including K1–K8, and the hair keratins, Hb1–Hb6. Keratin-1 is type II keratin. It is a specific marker for terminal differentiation in mammalian epidermis. It is specifically expressed in the spinous and gran µLar layers of the epidermis with family member KRT10 and mutations in these genes have been associated with b µLlous congenital ichthyosiform erythroderma. This antibody is specifically against ketatin I.
Immunogen : keratin 1
Aliases : 67 kDa cytokeratin, CK 1 CK1 Cytokeratin 1 keratin 1 KRT1
Observed MW : 67 kDa
Uniprot ID : P04264
Reactivity : Human, Mouse
Application : ELISA, IP, IF, WB, IHC
Recommended dilution : WB : 1 : 500-1 : 5000; IP : 1 : 200-1 : 2000; IHC : 1 : 20-1 : 200; IF : 1 : 20-1 : 200
Gene ID :
Research Area : Immunology, Developmental biology
0.01 0.01 USD
Cytokeratin 1 antibody
Volume : 100 µg
Purification : Immunogen affinity purified
Form : liquid
Purity : 95% as determined by SDS-PAGE
Host : Rabbit
Clonality : polyclonal Ab
Clone ID :
Isotype : IgG
Storage : PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20? for 12 months(Avoid repeated freeze / thaw cycles.)
Background : Keratins are a large family of proteins that form the intermediate filament cytoskeleton of epithelial cells, which are classified into two major sequence types. Type I keratins are a group of acidic intermediate filament proteins, including K9–K23, and the hair keratins Ha1–Ha8. Type II keratins are the basic or neutral courterparts to the acidic type I keratins, including K1–K8, and the hair keratins Ha1–Ha8. Type II keratins are the basic or neutral courterparts to the acidic type I keratins, including K1–K8, and the hair keratins, Hb1–Hb6. Keratin-1 is type II keratin. It is a specific marker for terminal differentiation in mammalian epidermis. It is specifically expressed in the spinous and gran µLar layers of the epidermis with family member KRT10 and mutations in these genes have been associated with b µLlous congenital ichthyosiform erythroderma. This antibody is specifically against ketatin I.
Immunogen : keratin 1
Aliases : 67 kDa cytokeratin, CK 1 CK1 Cytokeratin 1 keratin 1 KRT1
Observed MW : 67 kDa
Uniprot ID : P04264
Reactivity : Human, Mouse, Rat
Application : ELISA, WB, IHC
Recommended dilution : WB : 1 : 500-1 : 5000; IHC : 1 : 20-1 : 200
Gene ID :
Research Area :
0.01 0.01 USD
Cytohesin2 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYTH2
GeneID : 9266
Uniprot : Q99418
Specificity : Cytohesin2 Antibody detects endogenous levels of total Cytohesin2.
Immunogen : A syntheVolumed peptide derived from human Cytohesin2, corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat
Prediction : Pig,Bovine,Horse,Sheep,Dog
Application : WB,IHC
Dilution : WB 1 : 500-1 : 2000, IHC 1 : 50-1 : 200
Conj µgate : Unconj µgated
RRID : AB_2845554
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF12592-BP
Des# Blocking Peptide : Cytohesin2 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytohesin 3 antibody
Volume : 100 µg
Purification : Immunogen affinity purified
Form : liquid
Purity : 95% as determined by SDS-PAGE
Host : Rabbit
Clonality : polyclonal Ab
Clone ID :
Isotype : IgG
Storage : PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20? for 12 months(Avoid repeated freeze / thaw cycles.)
Background :
Immunogen : cytohesin 3
Aliases :
Observed MW : 46 kDa
Uniprot ID : O43739
Reactivity : Human, Mouse, Rat
Application : ELISA, WB
Recommended dilution : WB : 1 : 500-1 : 2000
Gene ID :
Research Area : Signal Transduction
0.01 0.01 USD
Cytohesin 2 antibody
Volume : 100 µg
Purification : Immunogen affinity purified
Form : liquid
Purity : 95% as determined by SDS-PAGE
Host : Rabbit
Clonality : polyclonal Ab
Clone ID :
Isotype : IgG
Storage : PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20? for 12 months(Avoid repeated freeze / thaw cycles.)
Background :
Immunogen : cytohesin 2
Aliases :
Observed MW : 47 kDa
Uniprot ID : Q99418
Reactivity : Human, Mouse, Rat
Application : ELISA, IHC, IF, WB, IP
Recommended dilution : WB : 1 : 500-1 : 2000; IP : 1 : 200-1 : 1000; IHC : 1 : 20-1 : 200; IF : 1 : 20-1 : 200
Gene ID :
Research Area : Signal Transduction
0.01 0.01 USD
Cytohesin 1 antibody
Volume : 100 µg
Purification : Immunogen affinity purified
Form : liquid
Purity : 95% as determined by SDS-PAGE
Host : Rabbit
Clonality : polyclonal Ab
Clone ID :
Isotype : IgG
Storage : PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20? for 12 months(Avoid repeated freeze / thaw cycles.)
Background :
Immunogen : cytohesin 1
Aliases :
Observed MW : 47 kDa
Uniprot ID : Q15438
Reactivity : Human, Mouse, Rat
Application : ELISA, WB
Recommended dilution : WB : 1 : 500-1 : 1000
Gene ID :
Research Area : Signal Transduction
0.01 0.01 USD
Cytoglobin/Histoglobin/HGb
Volume : 50 µg
Protein Type : Other proteins
Product Grade : For Research Use.
Tag : C-6His
Species : Human
Expressed In : E.coli
Note : Usually in stock. Smaller quantities and volume discounts are available. For further information, please contact us.
0.01 0.01 USD
Cytoglobin Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYGB
GeneID : 114757
Uniprot : Q8WWM9
Specificity : Cytoglobin Antibody detects endogenous levels of total Cytoglobin.
Immunogen : A syntheVolumed peptide derived from human Cytoglobin, corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat
Prediction : Pig,Bovine,Horse,Sheep,Rabbit,Dog,Chicken
Application : WB
Dilution : WB 1 : 500-1 : 2000
Conj µgate : Unconj µgated
RRID : AB_2845889
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF12928-BP
Des# Blocking Peptide : Cytoglobin Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 reductase Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : POR
GeneID : 5447
Uniprot : P16435
Specificity : Cytochrome P450 reductase Antibody detects endogenous levels of total Cytochrome P450 reductase.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 reductase, corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Reactivity : Human,Mouse,Rat
Prediction : Pig,Bovine,Horse,Sheep,Rabbit,Dog,Chicken,Xenopus
Application : WB,ELISA(peptide)
Dilution : WB 1 : 500-1 : 2000, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2839819
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF2613-BP
Des# Blocking Peptide : Cytochrome P450 reductase Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 8B1 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYP8B1
GeneID : 1582
Uniprot : Q9UNU6
Specificity : Cytochrome P450 8B1 Antibody detects endogenous levels of total Cytochrome P450 8B1.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 8B1 corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse
Prediction : Pig,Horse,Sheep,Rabbit,Dog
Application : WB,IHC,ELISA(peptide)
Dilution : WB 1 : 500-1 : 1000, IHC : 1 : 50-1 : 200, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2837116
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF4762-BP
Des# Blocking Peptide : Cytochrome P450 8B1 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 7B1 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYP7B1
GeneID : 9420
Uniprot : O75881
Specificity : Cytochrome P450 7B1 Antibody detects endogenous levels of total Cytochrome P450 7B1.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 7B1 corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human
Prediction : Pig,Bovine,Horse,Sheep,Rabbit,Dog
Application : WB,IF/ICC,ELISA(peptide)
Dilution : WB 1 : 500-1 : 1000, IF/ICC 1 : 100-1 : 500, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2835964
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF3592-BP
Des# Blocking Peptide : Cytochrome P450 7B1 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 7A1 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYP7A1
GeneID : 1581
Uniprot : P22680
Specificity : Cytochrome P450 7A1 Antibody detects endogenous levels of total Cytochrome P450 7A1.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 7A1 corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Reactivity : Human,Mouse,Rat
Prediction : Pig,Horse,Rabbit,Dog
Application : WB,IHC,IF/ICC,ELISA(peptide)
Dilution : WB 1 : 500-1 : 2000, IHC 1 : 50-1 : 200, ELISA(peptide) 1 : 20000-1 : 40000, IF/ICC 1 : 100-1 : 500
Conj µgate : Unconj µgated
RRID : AB_2839818
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF2612-BP
Des# Blocking Peptide : Cytochrome P450 7A1 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 51A1 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYP51A1
GeneID : 1595
Uniprot : Q16850
Specificity : Cytochrome P450 51A1 Antibody detects endogenous levels of total Cytochrome P450 51A1.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 51A1 corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human
Prediction : Pig,Dog
Application : WB,ELISA(peptide)
Dilution : WB 1 : 500-2000, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2835963
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF3591-BP
Des# Blocking Peptide : Cytochrome P450 51A1 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 4Z1/2 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYP4Z1
GeneID : 199974
Uniprot : Q86W10
Specificity : Cytochrome P450 4Z1/2 Antibody detects endogenous levels of total Cytochrome P450 4Z1/2.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 4Z1/2, corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat
Prediction :
Application : WB,IHC,IF/ICC,ELISA(peptide)
Dilution : WB 1 : 1000-3000, IF/ICC 1 : 100-1 : 500, IHC 1 : 50-1 : 200, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2840708
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF10128-BP
Des# Blocking Peptide : Cytochrome P450 4Z1/2 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 4X1 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYP4X1
GeneID : 260293
Uniprot : Q8N118
Specificity : Cytochrome P450 4X1 Antibody detects endogenous levels of total Cytochrome P450 4X1.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 4X1 corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat,Monkey
Prediction : Dog
Application : WB,IHC,IF/ICC,ELISA(peptide)
Dilution : WB 1 : 500-1 : 1000, IHC : 1 : 50-1 : 200, IF/ICC 1 : 100-1 : 500, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2835961
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF3589-BP
Des# Blocking Peptide : Cytochrome P450 4X1 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 4V2 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYP4V2
GeneID : 285440
Uniprot : Q6ZWL3
Specificity : Cytochrome P450 4V2 Antibody detects endogenous levels of total Cytochrome P450 4V2.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 4V2, corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse
Prediction :
Application : WB,IHC,IF/ICC,ELISA(peptide)
Dilution : WB 1 : 500-1 : 1000, IHC : 1 : 50-1 : 200, IF/ICC 1 : 100-1 : 500, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2837095
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF4744-BP
Des# Blocking Peptide : Cytochrome P450 4V2 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 4F8 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYP4F8
GeneID : 11283
Uniprot : P98187
Specificity : Cytochrome P450 4F8 Antibody detects endogenous levels of total Cytochrome P450 4F8.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 4F8, corresponding to a region within C-terminal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human
Prediction : Dog
Application : WB,ELISA(peptide)
Dilution : WB 1 : 1000-3000, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2842124
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF8928-BP
Des# Blocking Peptide : Cytochrome P450 4F8 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 4F3 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYP4F3
GeneID : 4051
Uniprot : Q08477
Specificity : Cytochrome P450 4F3 Antibody detects endogenous levels of total Cytochrome P450 4F3.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 4F3, corresponding to a region within N-terminal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human
Prediction : Dog
Application : WB,ELISA(peptide)
Dilution : WB 1 : 1000-3000, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2842123
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF8927-BP
Des# Blocking Peptide : Cytochrome P450 4F3 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 4F22 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYP4F22
GeneID : 126410
Uniprot : Q6NT55
Specificity : Cytochrome P450 4F22 Antibody detects endogenous levels of total Cytochrome P450 4F22.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 4F22, corresponding to a region within C-terminal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse
Prediction : Pig,Bovine,Horse,Sheep,Rabbit,Dog
Application : WB,ELISA(peptide)
Dilution : WB 1 : 1000-3000, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2842125
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF8929-BP
Des# Blocking Peptide : Cytochrome P450 4F22 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 4F12 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYP4F12
GeneID : 66002
Uniprot : Q9HCS2
Specificity : Cytochrome P450 4F12 Antibody detects endogenous levels of total Cytochrome P450 4F12.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 4F12, corresponding to a region within N-terminal amino acids.
Storage : Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Reactivity : Human,Mouse
Prediction :
Application : WB,IHC,ELISA(peptide)
Dilution : WB 1 : 500-1 : 2000, IHC 1 : 50-1 : 200, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2839820
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF2614-BP
Des# Blocking Peptide : Cytochrome P450 4F12 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 4F11 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYP4F11
GeneID : 57834
Uniprot : Q9HBI6
Specificity : Cytochrome P450 4F11 Antibody detects endogenous levels of total Cytochrome P450 4F11.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 4F11 corresponding to a region within C-terminal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human
Prediction :
Application : WB,IF/ICC,ELISA(peptide)
Dilution : WB 1 : 500-1 : 1000, IF/ICC 1 : 100-1 : 500, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2837104
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF4750-BP
Des# Blocking Peptide : Cytochrome P450 4F11 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 4B1 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYP4B1
GeneID : 1580
Uniprot : P13584
Specificity : Cytochrome P450 4B1 Antibody detects endogenous levels of total Cytochrome P450 4B1.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 4B1 corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse
Prediction :
Application : WB,IHC,IF/ICC,ELISA(peptide)
Dilution : WB 1 : 500-1 : 1000, IHC : 1 : 50-1 : 200, IF/ICC 1 : 100-1 : 500, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2835960
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF3588-BP
Des# Blocking Peptide : Cytochrome P450 4B1 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 4A11/22 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYP4A11CYP4A22
GeneID : 1579,284541
Uniprot : Q02928/Q5TCH4
Specificity : Cytochrome P450 4A11/22 Antibody detects endogenous levels of total Cytochrome P450 4A11/22.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 4A11/22, corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human
Prediction : Bovine,Dog
Application : WB,IF/ICC,ELISA(peptide)
Dilution : WB 1 : 500-1 : 1000, IF/ICC 1 : 100-1 : 500, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2837103
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF4749-BP
Des# Blocking Peptide : Cytochrome P450 4A11/22 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 46A1 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYP46A1
GeneID : 10858
Uniprot : Q9Y6A2
Specificity : Cytochrome P450 46A1 Antibody detects endogenous levels of total Cytochrome P450 46A1.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 46A1 corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Monkey
Prediction : Pig,Horse,Rabbit,Dog
Application : WB,IHC,ELISA(peptide)
Dilution : WB 1 : 1000-3000, IHC 1 : 50-1 : 200, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2842122
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF8926-BP
Des# Blocking Peptide : Cytochrome P450 46A1 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 3A7 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYP3A7
GeneID : 100861540,1551
Uniprot : P24462
Specificity : Cytochrome P450 3A7 Antibody detects endogenous levels of total Cytochrome P450 3A7.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 3A7, corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Rat
Prediction :
Application : WB,ELISA(peptide)
Dilution : WB 1 : 500-1 : 1000, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2837102
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF4748-BP
Des# Blocking Peptide : Cytochrome P450 3A7 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 3A43 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName :
GeneID :
Uniprot : Q9HB51
Specificity : Cytochrome P450 3A43 Antibody detects endogenous levels of total Cytochrome P450 3A43.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 3A43
Storage : Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Reactivity : Human
Prediction :
Application : WB,IHC,ELISA(peptide)
Dilution : WB 1 : 500-1 : 2000, IHC 1 : 50-1 : 200, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2839822
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF2616-BP
Des# Blocking Peptide : Cytochrome P450 3A43 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD
Cytochrome P450 3A4/5 Antibody
Volume : 100 µL
Host : Rabbit
Clonality : polyclonal Ab
Isotype : IgG
GeneName : CYP3A5,CYP3A4
GeneID : 1577,1576
Uniprot : P08684/P20815
Specificity : Cytochrome P450 3A4/5 Antibody detects endogenous levels of total Cytochrome P450 3A4/5.
Immunogen : A syntheVolumed peptide derived from human Cytochrome P450 3A4/5, corresponding to a region within the internal amino acids.
Storage : Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
Reactivity : Human,Mouse,Rat
Prediction : Bovine,Dog
Application : WB,IF/ICC,ELISA(peptide)
Dilution : WB 1 : 500-1 : 1000, IF/ICC 1 : 100-1 : 500, ELISA(peptide) 1 : 20000-1 : 40000
Conj µgate : Unconj µgated
RRID : AB_2835958
An Introduction to Blocking Peptides : A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.
Cat# Blocking Peptide : DF3586-BP
Des# Blocking Peptide : Cytochrome P450 3A4/5 Blocking peptide
Blocking Peptide Price : $549 CAD
0.01 0.01 USD